Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease.

Parkinsonism & Related Disorders
Cristina RascunàAlessandra Nicoletti

Abstract

Retinal impairment has previously been described in Parkinson's Disease (PD), also in early stage of disease. Idiopathic Rapid-eye-movement sleep Behavior Disorder (iRBD) is considered the strongest marker in the diagnosis of "Prodromal PD". Thus, we evaluated the thickness of retinal layers and the microvascular retinal pattern in a group of iRBD patients compared to PD and healthy subjects (HCs). retinal layer's thickness and microvascular pattern among PD, iRBD and HCs were assessed using Spectral-Density Optical Coherence Tomography (SD-OCT) and OCT-Angiography (OCT-A), respectively. Forty-one eyes from 21 PD, 37 eyes from 19 iRBD and 33 eyes from 17 HCs were analysed. Peripapillary Retinal Nerve Fiber Layer (RNFL) was thinner in PD and RBD compared to HCs. All macular retinal layers, except for retinal pigment epithelium, resulted to be significantly thinner in iRBD and in PD compared to HCs, also adjusting by age, sex and hypertension. Macular RNFL and ganglionic cell layer were thinner in PD compared to iRBD. Moreover, in iRBD, a peculiar microvascular pattern was found, characterized by a higher vascularization of the deep capillary plexus with respect both PD patients and HCs. in PD and iRBD patients retina was thinner...Continue Reading

References

Sep 1, 1982·The Journal of Comparative Neurology·J M FrederickJ G Hollyfield
Nov 17, 2009·Lancet Neurology·Dennis W DicksonIrene Litvan
Jul 14, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Ellison Fernando CardosoEdson Amaro
Dec 23, 2011·Parkinsonism & Related Disorders·Etienne C HirschStéphane Hunot
Mar 23, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C La MorgiaV Carelli
Jun 26, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaJacques Y Montplaisir
Aug 18, 2012·Brain Pathology·Jian GuanLouise F B Nicholson
Jan 8, 2013·Neurochemistry International·Juliet M TaylorPeter J Crack
Nov 11, 2014·Cold Spring Harbor Perspectives in Biology·Jordan S Pober, William C Sessa
Oct 8, 2015·Journal of Parkinson's Disease·Panzao YangJian Guan
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaGünther Deuschl
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Daniela BergGünther Deuschl
May 18, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Erik K St LouisBradley F Boeve
Jul 22, 2017·Frontiers in Aging Neuroscience·Ana I RamirezJosé M Ramírez
May 9, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Isabel Ortuño-LizaránNicolás Cuenca
Jun 1, 2018·Journal of Immunology Research·Géraldine GeldersAnke Van der Perren
Feb 6, 2019·Acta Neuropathologica·Lien VeysLies De Groef
Feb 23, 2019·Brain : a Journal of Neurology·Ronald B PostumaAmelie Pelletier
Nov 12, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Jee-Young LeeBeomseok Jeon
Oct 30, 2020·Frontiers in Neurology·Cristina RascunàAlessandra Nicoletti

❮ Previous
Next ❯

Citations

Oct 7, 2021·Seminars in Ophthalmology·Evita Evangelia ChristouSpiridon Konitsiotis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.